VACCINEX, INC. Quarterly Costs and Expenses in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Vaccinex, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2017 to Q3 2024.
  • Vaccinex, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $4.6M, a 21.4% decline year-over-year.
  • Vaccinex, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $20.7M, a 13% decline year-over-year.
  • Vaccinex, Inc. annual Costs and Expenses for 2023 was $23.5M, a 16.2% increase from 2022.
  • Vaccinex, Inc. annual Costs and Expenses for 2022 was $20.2M, a 13.7% decline from 2021.
  • Vaccinex, Inc. annual Costs and Expenses for 2021 was $23.4M, a 19.2% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $20.7M $4.6M -$1.25M -21.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $22M $5.95M -$1.12M -15.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $23.1M $5.18M -$358K -6.47% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $23.5M $4.99M -$356K -6.66% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-04-25
Q3 2023 $23.8M $5.85M +$1.01M +20.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $22.8M $7.08M +$1.68M +31% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $21.1M $5.54M +$942K +20.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $20.2M $5.34M -$174K -3.15% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-04-25
Q3 2022 $20.4M $4.84M -$271K -5.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $20.6M $5.4M -$268K -4.73% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $20.9M $4.59M -$2.5M -35.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $23.4M $5.52M -$571K -9.38% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $24M $5.11M -$4.1M -44.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $28.1M $5.67M -$831K -12.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $28.9M $7.09M -$69K -0.96% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $29M $6.09M -$250K -3.94% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $29.2M $9.21M +$1.13M +13.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $28.1M $6.5M -$2.38M -26.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $30.5M $7.16M -$2.08M -22.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $32.5M $6.34M -$2.42M -27.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $35M $8.08M +$1.43M +21.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $33.5M $8.88M +$2.2M +32.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $31.3M $9.23M +$3.32M +56.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $28M $8.76M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 $6.65M +$1.32M +24.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $6.68M +$2.02M +43.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $5.92M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q3 2017 $5.33M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $4.67M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.